文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

白细胞介素 32γ(IL-32γ)在美洲皮肤利什曼病患者的皮肤和黏膜病变中高度表达:与肿瘤坏死因子(TNF)和白细胞介素 10 相关。

Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.

机构信息

Institute of Tropical Pathology and Public Healthy, Universidade Federal de Goiás, Rua 235 S/N - Setor Universitário, Goiânia 74605-050, Goiás, Brazil.

出版信息

BMC Infect Dis. 2014 May 9;14:249. doi: 10.1186/1471-2334-14-249.


DOI:10.1186/1471-2334-14-249
PMID:24884781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4026597/
Abstract

BACKGROUND: The interleukin 32 (IL-32) is a proinflammatory cytokine produced by immune and non-immune cells. It can be induced during bacterial and viral infections, but its production was never investigated in protozoan infections. American Tegumentary Leishmaniasis (ATL) is caused by Leishmania protozoan leading to cutaneous, nasal or oral lesions. The aim of this study was to evaluate the expression of IL-32 in cutaneous and mucosal lesions as well as in peripheral blood mononuclear cells (PBMC) exposed to Leishmania (Viannia) braziliensis. METHODS: IL-32, tumour necrosis factor (TNF) and IL-10 protein expression was evaluated by immunohistochemistry in cutaneous, mucosal lesions and compared to healthy specimens. The isoforms of IL-32α, β, δ, γ mRNA, TNF mRNA and IL-10 mRNA were assessed by qPCR in tissue biopsies of lesions and healthy skin and mucosa. In addition, PBMC from healthy donors were cultured with amastigotes of L. (V.) braziliensis. In lesions, the parasite subgenus was identified by PCR-RFLP. RESULTS: We showed that the mRNA expression of IL-32, in particular IL-32γ was similarly up-regulated in lesions of cutaneous (CL) or mucosal (ML) leishmaniasis patients. IL-32 protein was produced by epithelial, endothelial, mononuclear cells and giant cells. The IL-32 protein expression was associated with TNF in ML but not in CL. IL-32 was not associated with IL-10 in both CL and ML. Expression of TNF mRNA was higher in ML than in CL lesions, however levels of IL-10 mRNA were similar in both clinical forms. In all lesions in which the parasite was detected, L. (Viannia) subgenus was identified. Interestingly, L. (V.) braziliensis induced only IL-32γ mRNA expression in PBMC from healthy individuals. CONCLUSIONS: These data suggest that IL-32 plays a major role in the inflammatory process caused by L. (Viannia) sp or that IL-32 is crucial for controlling the L. (Viannia) sp infection.

摘要

背景:白细胞介素 32(IL-32)是一种由免疫和非免疫细胞产生的促炎细胞因子。它可以在细菌和病毒感染期间被诱导,但从未在原生动物感染中研究过其产生。美洲皮肤利什曼病(ATL)是由原生动物利什曼引起的,导致皮肤、鼻腔或口腔病变。本研究旨在评估白细胞介素 32(IL-32)在皮肤和粘膜病变以及暴露于 Leishmania(Viannia)braziliensis 的外周血单个核细胞(PBMC)中的表达。

方法:通过免疫组织化学评估皮肤、粘膜病变以及与健康标本相比的白细胞介素 32(IL-32)、肿瘤坏死因子(TNF)和白细胞介素 10(IL-10)蛋白表达。通过 qPCR 评估组织活检中病变和健康皮肤和粘膜的 IL-32α、β、δ、γ mRNA、TNF mRNA 和 IL-10 mRNA 同工型。此外,从健康供体的 PBMC 中培养 L.(V.)braziliensis 无鞭毛体。在病变中,通过 PCR-RFLP 鉴定寄生虫亚属。

结果:我们表明,皮肤(CL)或粘膜(ML)利什曼病患者的病变中 IL-32,特别是 IL-32γ 的 mRNA 表达相似地上调。IL-32 蛋白由上皮细胞、内皮细胞、单核细胞和巨细胞产生。在 ML 中,IL-32 蛋白表达与 TNF 相关,但在 CL 中则不然。CL 和 ML 中 IL-32 与 IL-10 均无关。ML 病变中 TNF mRNA 的表达高于 CL 病变,但两种临床形式的 IL-10 mRNA 水平相似。在检测到寄生虫的所有病变中,均鉴定出 L.(Viannia)亚属。有趣的是,L.(V.)braziliensis 仅诱导来自健康个体的 PBMC 中 IL-32γ mRNA 的表达。

结论:这些数据表明,IL-32 在 L.(Viannia)sp 引起的炎症过程中起主要作用,或者 IL-32 对控制 L.(Viannia)sp 感染至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/18c4365f3b41/1471-2334-14-249-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/2fc15e2bc9ce/1471-2334-14-249-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/6b1133b04ab6/1471-2334-14-249-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/eb90735788f7/1471-2334-14-249-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/9b33fd8dd697/1471-2334-14-249-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/01b4c4edde3c/1471-2334-14-249-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/18c4365f3b41/1471-2334-14-249-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/2fc15e2bc9ce/1471-2334-14-249-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/6b1133b04ab6/1471-2334-14-249-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/eb90735788f7/1471-2334-14-249-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/9b33fd8dd697/1471-2334-14-249-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/01b4c4edde3c/1471-2334-14-249-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b05/4026597/18c4365f3b41/1471-2334-14-249-6.jpg

相似文献

[1]
Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.

BMC Infect Dis. 2014-5-9

[2]
IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.

Parasit Vectors. 2017-7-14

[3]
The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis.

Cytokine. 2014-4

[4]
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

J Exp Med. 1995-4-1

[5]
Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production.

BMC Infect Dis. 2006-4-25

[6]
Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis.

Front Cell Infect Microbiol. 2019-5-2

[7]
Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.

Parasit Vectors. 2016-6-27

[8]
American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease.

Immunobiology. 2016-2

[9]
Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals.

Microb Pathog. 2013-2-19

[10]
Leishmania (Viannia) braziliensis amastigotes induces the expression of TNFα and IL-10 by human peripheral blood mononuclear cells in vitro in a TLR4-dependent manner.

Cytokine. 2016-12

引用本文的文献

[1]
IL-32-producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis.

J Clin Invest. 2025-5-15

[2]
Single-nucleotide polymorphisms in genes associated with the vitamin D pathway related to clinical and therapeutic outcomes of American tegumentary leishmaniasis.

Front Cell Infect Microbiol. 2025-1-8

[3]
IL-32 as a potential biomarker and therapeutic target in skin inflammation.

Front Immunol. 2023

[4]
Host SUMOylation Pathway Negatively Regulates Protective Immune Responses and Promotes Survival.

Front Cell Infect Microbiol. 2022

[5]
Lipophosphoglycan From Dermotropic New World Upregulates Interleukin-32 and Proinflammatory Cytokines Through TLR4 and NOD2 Receptors.

Front Cell Infect Microbiol. 2022

[6]
A Critical Overview of Interleukin 32 in Leishmaniases.

Front Immunol. 2022

[7]
Interleukin-32 in the Control of Acute Experimental Chagas Disease.

J Immunol Res. 2022

[8]
Genetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary Leishmaniasis.

PLoS Negl Trop Dis. 2020-2-5

[9]
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Front Immunol. 2019-4-5

[10]
Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Infection of Human Macrophages.

Front Immunol. 2018-7-31

本文引用的文献

[1]
Cutaneous leishmaniasis in northeastern Brazil: a critical appraisal of studies conducted in State of Pernambuco.

Rev Soc Bras Med Trop. 2012-7-26

[2]
Cutaneous and mucocutaneous leishmaniasis.

Infect Dis Clin North Am. 2012-4-17

[3]
Regulation and expression of IL-32 in chronic rhinosinusitis.

Allergy. 2012-4-9

[4]
NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.

Nat Med. 2012-3-25

[5]
Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection.

Cytokine. 2012-1-25

[6]
IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.

Int Immunol. 2011-10-27

[7]
Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps.

Allergy. 2011-9-7

[8]
Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis.

Braz J Otorhinolaryngol. 2011-6

[9]
miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization.

PLoS One. 2011-5-17

[10]
IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis.

J Pathol. 2011-5-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索